SE385698B - Forfarande for framstellning av kinolinettiksyraderivat - Google Patents

Forfarande for framstellning av kinolinettiksyraderivat

Info

Publication number
SE385698B
SE385698B SE7302069A SE7302069A SE385698B SE 385698 B SE385698 B SE 385698B SE 7302069 A SE7302069 A SE 7302069A SE 7302069 A SE7302069 A SE 7302069A SE 385698 B SE385698 B SE 385698B
Authority
SE
Sweden
Prior art keywords
quinolinetic
procedure
preparation
acid derivatives
derivatives
Prior art date
Application number
SE7302069A
Other languages
English (en)
Swedish (sv)
Inventor
R Goschke
Original Assignee
Ciba Geigy Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ciba Geigy Ag filed Critical Ciba Geigy Ag
Publication of SE385698B publication Critical patent/SE385698B/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D215/00Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/12Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D215/00Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/18Halogen atoms or nitro radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D215/00Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/20Oxygen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D215/00Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/20Oxygen atoms
    • C07D215/24Oxygen atoms attached in position 8
    • C07D215/26Alcohols; Ethers thereof

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Quinoline Compounds (AREA)
SE7302069A 1972-03-10 1973-02-14 Forfarande for framstellning av kinolinettiksyraderivat SE385698B (sv)

Applications Claiming Priority (10)

Application Number Priority Date Filing Date Title
CH354972A CH567477A5 (fr) 1972-03-10 1972-03-10
CH692175A CH576447A5 (fr) 1972-03-10 1972-03-10
CH691875A CH576445A5 (fr) 1972-03-10 1972-03-10
CH691675A CH603587A5 (fr) 1972-03-10 1972-03-10
CH691975A CH578533A5 (fr) 1972-03-10 1972-03-10
CH691775A CH576963A5 (fr) 1972-03-10 1972-03-10
CH123073 1973-01-29
US337998A US3897436A (en) 1972-03-10 1973-03-05 Quinolineacetic acid derivatives
AU53078/73A AU478645B2 (en) 1972-03-10 1973-03-08 New quinolineacetic acid derivatives and processes for their manufacture
US05/573,274 US3973022A (en) 1972-03-10 1975-04-29 Quinolineacetic acid compositions

Publications (1)

Publication Number Publication Date
SE385698B true SE385698B (sv) 1976-07-19

Family

ID=27578968

Family Applications (1)

Application Number Title Priority Date Filing Date
SE7302069A SE385698B (sv) 1972-03-10 1973-02-14 Forfarande for framstellning av kinolinettiksyraderivat

Country Status (12)

Country Link
US (2) US3897436A (fr)
JP (1) JPS49274A (fr)
AT (2) AT327906B (fr)
AU (1) AU478645B2 (fr)
BE (1) BE796519A (fr)
CA (1) CA1010872A (fr)
CH (6) CH576447A5 (fr)
DE (1) DE2310773A1 (fr)
FR (1) FR2181801B1 (fr)
GB (1) GB1404392A (fr)
NL (1) NL7303377A (fr)
SE (1) SE385698B (fr)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5116973U (fr) * 1974-07-25 1976-02-06
US3991061A (en) * 1975-07-16 1976-11-09 G. D. Searle & Co. Azanaphthaleneacetic acid derivatives
US4392081A (en) * 1981-07-31 1983-07-05 General Electric Company Lighting unit
JPS58116466A (ja) * 1981-12-29 1983-07-11 Nippon Zoki Pharmaceut Co Ltd 新規キノリル酢酸誘導体及び該化合物を含有する医薬組成物
US4968701A (en) * 1988-04-26 1990-11-06 E. I. Du Pont De Nemours And Company 4-Quinoline carboxylic acid derivatives useful as immunosuppressive agents
US5204329A (en) * 1990-06-11 1993-04-20 Du Pont Merck Pharmaceutical Company Treatment of organ transplantation rejection
JP3209568B2 (ja) * 1991-04-16 2001-09-17 杏林製薬株式会社 新規環状アミノフェニル酢酸誘導体、その製造法及びそれらを有効成分とする免疫応答の修飾剤
JP3528186B2 (ja) * 1991-06-24 2004-05-17 日産化学工業株式会社 光学活性キノリンメバロン酸のジアステレオマー塩
US6037376A (en) * 1991-10-21 2000-03-14 The United States Of America As Represented By The Department Of Health And Human Services Methods for therapy of cancer
US5635532A (en) * 1991-10-21 1997-06-03 The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Compositions and methods for therapy and prevention of pathologies including cancer, AIDS and anemia
US5605930A (en) * 1991-10-21 1997-02-25 The United States Of America As Represented By The Department Of Health And Human Services Compositions and methods for treating and preventing pathologies including cancer
KR20010014030A (ko) 1997-06-19 2001-02-26 더글라스이.리디치 퀴놀린-인돌 항균제, 이들의 용도 및 조성물
US6103905A (en) * 1997-06-19 2000-08-15 Sepracor, Inc. Quinoline-indole antimicrobial agents, uses and compositions related thereto
US6376670B1 (en) 1997-06-19 2002-04-23 Sepracor Inc. Quinoline-indole antimicrobial agents, uses and compositions related thereto
US6207679B1 (en) 1997-06-19 2001-03-27 Sepracor, Inc. Antimicrobial agents uses and compositions related thereto

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2042352A1 (fr) * 1969-04-21 1971-02-12 Ciba Geigy Ag Acides alpha-(1,2,3,4-tetrahydro-6-quinolyl)-carboxyliques et leurs derives

Also Published As

Publication number Publication date
CH567477A5 (fr) 1975-10-15
US3973022A (en) 1976-08-03
FR2181801A1 (fr) 1973-12-07
GB1404392A (en) 1975-08-28
NL7303377A (fr) 1973-09-12
ATA90075A (de) 1976-04-15
ATA210673A (de) 1975-05-15
FR2181801B1 (fr) 1976-10-22
CH578533A5 (fr) 1976-08-13
DE2310773A1 (de) 1973-09-20
AT327906B (de) 1976-02-25
AU478645B2 (en) 1974-09-12
CH576447A5 (fr) 1976-06-15
AU5307873A (en) 1974-09-12
CH576963A5 (fr) 1976-06-30
JPS49274A (fr) 1974-01-05
CA1010872A (en) 1977-05-24
US3897436A (en) 1975-07-29
BE796519A (fr) 1973-09-10
CH576445A5 (fr) 1976-06-15
CH603587A5 (fr) 1978-08-31
AT333760B (de) 1976-12-10

Similar Documents

Publication Publication Date Title
SE407579B (sv) Forfarande for framstellning av n-fosfonometylglycin
SE398229B (sv) Forfarande for framstellning av 4-fenoxi-fenoxialkankarbonsyraderivat
NO140731C (no) Fremgangsmaate for fremstilling av dimetyleter
SE395149B (sv) Forfarande for framstellning av dibenso-tiepinylpiperazinderivat
SE403106B (sv) Forfarande vid framstellning av 14-hydroximorfinanderivat
SE401676B (sv) Forfarande for framstellning av dibensofuranderivat
SE385698B (sv) Forfarande for framstellning av kinolinettiksyraderivat
SE7700442L (sv) Forfarande for framstellning av 6-aminopenicillansyra
SE386892B (sv) Forfarande for framstellning av oxaminoforeningar
SE382053B (sv) Forfarande for framstellning av bifenylylalkanoylaminopyridiner
SE383151B (sv) Forfarande for framstellning av 1-hydroxi-2-pyridoner
SE399708B (sv) Forfarande for framstellning av tioxanton-2-karboxylsyraderivat
SE399425B (sv) Forfarande for framstellning av 1-fenoxi-3-aminopropan-2-ol-derivat
SE402009B (sv) Forfarande for framstellning av 9-desoxi-prosta-5,9,(10),13-triensyraderivat
SE380272B (sv) Forfarande for framstellning av n-fosfonmetylglycin
SE393111B (sv) Forfarande for framstellning av d-2-halogen-6-metyl-8-substituerad - ergolin
NO142307C (no) Fremgangsmaate ved fremstilling av pregnansyrederivater
SE393801B (sv) Forfarande for framstellning av tiokarbaminsyraderivat med antifungistatisk lekemedelsverken
FI56830B (fi) Foerfarande foer framstaellning av asparaginylgrupper innehaollande biologiskt aktiva polypeptider
SE393808B (sv) Forfarande for framstellning av isomaltit
SE415355B (sv) Forfarande for framstellning av fosfonotioureider
NO140736C (no) Fremgangsmaate til fremstilling av poly-alfa-oksyakrylsyre
SE391717B (sv) Forfarande for framstellning av 4-aryl-5-aminoalkyl-4-oxazolin-2-oner
SE400287B (sv) Forfarande for framstellning av fluorsubstituerade tiaxantenderivat
SE404367B (sv) Forfarande for framstellning av derivat av homofolsyra